Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$360M
1 round on record
Latest round
$360M
Venture round · Jun 2022 · 4 yr ago
Team
501-1000
employees, estimated range
Backers
2
ARCH Venture Partners, GV
The money's age
Long since its last round
52 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2022 | $360M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Areteia Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jorge BartolomeExecutive Officer, DirectorSEC Form D
Christopher CourtsExecutive OfficerSEC Form D
Robin WalkerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
People

Jorge Bartolome
Executive Officer, Director

Christopher Courts
Executive Officer

Robin Walker
Executive Officer

Paul Berns
Director

Adam Koppel
Director

Ian Read
Director

Benjamin Gomez
Director

Michael Bozik
Director

Stephen Butts
Director

Elyse Stock
Director

Daniel Becker
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chapel Hill
United States
HQ
500-1000 est. staff
Financials
Total raised
$360M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $360M | Details |

ARCH Venture Partners
GV